SSRI vs SNRI for Anxiety: Which Is Better? A Canadian Patient Guide
Both classes are first-line for anxiety in Canada. Here's what the evidence actually says about efficacy, side effects, dosing, and provincial coverage — and how to pick the right one for you.
If your doctor has suggested medication for anxiety, you've probably heard of two classes: SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are recommended as first-line treatment for generalized anxiety disorder, social anxiety disorder, and panic disorder by the American Academy of Family Physicians and the 2022 JAMA review of anxiety disorders. The big question patients ask: which is better? The honest, evidence-based answer is that they're equivalent in efficacy for most patients — and the choice usually comes down to side effects, prior response, formulary access, and personal preference.
If You're in Crisis
If you're having thoughts of self-harm or suicide, call or text 9-8-8 (Canada Suicide Crisis Helpline), available 24/7, free, and confidential.
The Bottom Line First
- Efficacy is roughly equal. By week 8, SSRIs and SNRIs produce comparable anxiety symptom reduction. Don't assume one is “stronger.”
- SSRIs are usually first. Lower side-effect burden, neutral cardiovascular profile, broader formulary access in Canada.
- SNRIs are a strong second-line — especially venlafaxine XR — and are first-line for some patients (e.g., comorbid chronic pain favors duloxetine).
- Sertraline, escitalopram, and venlafaxine XR are the three medications a Canadian family physician will most often start with.
- Effect sizes are mild to moderate (standardized mean differences typically 0.37-0.56). Therapy + medication outperforms either alone.
How They Work
SSRIs
Selectively block the reabsorption of serotonin into nerve cells, increasing the available serotonin between neurons. Affect mood, anxiety, sleep, and appetite circuits.
Common in Canada: sertraline (Zoloft), escitalopram (Cipralex), citalopram (Celexa), fluoxetine (Prozac), paroxetine (Paxil), fluvoxamine (Luvox).
SNRIs
Block reabsorption of both serotonin and norepinephrine. The added noradrenergic effect can help energy and pain symptoms but increases blood pressure and heart rate.
Common in Canada: venlafaxine XR (Effexor XR), duloxetine (Cymbalta), desvenlafaxine (Pristiq).
Efficacy: What the Evidence Shows
The largest and most rigorous comparison comes from a 2021 three-level network meta-analysis published in PLOS Medicine, which pooled 135 trials and over 30,000 participants. It found that all SSRIs and SNRIs were effective for anxiety disorders, with only small, non-statistically-significant differences between individual medications. A 2024 Bayesian hierarchical modeling meta-analysis of 122 trials reached the same conclusion: by week 8, the two classes produce equivalent anxiety symptom reduction.
For generalized anxiety disorder specifically, a Lancet network meta-analysis ranked duloxetine, venlafaxine, escitalopram, and pregabalin among the most efficacious agents — but again, the differences between SSRIs and SNRIs as classes were not statistically significant. Response rates for first-line pharmacotherapy in GAD are about 30-50%, with overall response to any first-line medication around 67%.
One subtle but real difference: dose-response curves diverge. SSRIs improve more at higher doses within the therapeutic range. If sertraline 50 mg isn't cutting it, going to 100 mg or 150 mg often helps. SNRIs do not get more effective at higher doses — increasing the dose mostly increases side effects without additional benefit. This is a meaningful clinical distinction your doctor will keep in mind.
Side Effects: Where They Differ
| Side Effect | SSRIs | SNRIs |
|---|---|---|
| Nausea, headache (early) | Common; usually resolves in 1-2 weeks | Common; usually resolves in 1-2 weeks |
| Sexual dysfunction | Common (decreased libido, delayed orgasm) | Common; rates similar to SSRIs |
| Insomnia or sedation | Variable; fluoxetine more activating | Venlafaxine can be activating |
| Blood pressure increase | Neutral | Dose-dependent rise — monitor BP |
| Heart rate increase | Neutral | Modest increase, especially venlafaxine |
| Discontinuation syndrome | Mild-moderate; worse with paroxetine | More pronounced with venlafaxine |
| QT prolongation | Rare; citalopram dose-capped | Rare |
| Hyponatremia (low sodium) | Risk in older adults | Risk in older adults |
Across pooled studies, about 80% of patients on either class experience at least one side effect — but most are mild and resolve within 1-2 weeks. The standout exceptions are sertraline and fluoxetine, where adverse-event rates are not statistically different from placebo. If side effects are your main worry, those two are reasonable starting points.
Health Canada Approvals for Anxiety
Health Canada approval matters because it influences provincial formulary coverage. Off-label prescribing is legal and supported by evidence, but covered medications are easier to access. Approved indications for anxiety as of April 2026:
- Paroxetine (Paxil) — GAD, social anxiety, panic disorder, OCD
- Escitalopram (Cipralex) — GAD, social anxiety
- Sertraline (Zoloft) — Social anxiety, panic disorder, OCD (not GAD, despite strong evidence)
- Fluoxetine (Prozac) — OCD, panic disorder
- Fluvoxamine (Luvox) — OCD
- Venlafaxine XR (Effexor XR) — GAD, social anxiety, panic disorder
- Duloxetine (Cymbalta) — GAD only
- Citalopram (Celexa) — Not Health Canada–approved for any anxiety disorder, though widely prescribed off-label
Provincial Coverage in Ontario, BC, and Alberta
| Medication | ODB (Ontario) | BC PharmaCare | Alberta Blue Cross |
|---|---|---|---|
| Sertraline (generic) | General benefit | LU criteria | General benefit |
| Escitalopram (generic) | LU criteria | LU criteria | SA required |
| Citalopram (generic) | General benefit | General benefit | General benefit |
| Fluoxetine (generic) | General benefit | General benefit | General benefit |
| Paroxetine (generic) | General benefit | General benefit | General benefit |
| Venlafaxine XR (generic) | General benefit | General benefit | General benefit |
| Duloxetine (generic) | LU criteria | SA required | SA for anxiety |
LU = Limited Use (specific clinical criteria must be met); SA = Special Authorization (separate request to provincial plan). Coverage rules change — your pharmacist can confirm before you fill. See our medication-specific cost guides: sertraline, escitalopram, venlafaxine, duloxetine.
When SSRI Is Usually the Better Choice
- Cardiovascular disease, hypertension, or arrhythmia — SSRIs are cardiovascularly neutral; SNRIs raise blood pressure and heart rate.
- Older adults (65+) — SSRIs (especially sertraline, escitalopram) have stronger evidence and a better tolerability profile in seniors.
- Pregnancy — Sertraline and escitalopram have the most reassuring safety data; SNRIs have less.
- You want lower side-effect risk — Sertraline and fluoxetine have the lowest adverse-event rates in head-to-head studies.
- Cost-sensitive patients — All major SSRIs are widely available as cheap generics under provincial plans.
When SNRI Might Be the Better Choice
- Comorbid chronic pain — Duloxetine is also approved for diabetic neuropathy, fibromyalgia, and chronic musculoskeletal pain. One medication, two indications.
- Failure of one or more SSRIs — Switching to an SNRI is the most common second-line strategy and has good response rates.
- Significant fatigue with anxiety — The noradrenergic component of SNRIs can be activating in patients with low energy.
- GAD specifically — Venlafaxine and duloxetine have direct Health Canada approval for GAD and rank among the most efficacious agents in network meta-analyses.
Starting Doses for Anxiety (Lower Than for Depression)
Anxiety patients are often more sensitive to early activation side effects (jitteriness, insomnia, GI upset). The general principle is “start low, go slow” — typically half the depression starting dose, with titration over 1-2 weeks to the therapeutic dose.
- Sertraline: start 25 mg; target 50-200 mg/day
- Escitalopram: start 5 mg; target 10-20 mg/day
- Citalopram: start 10 mg; target 20-40 mg/day (max 20 mg if >60 years)
- Fluoxetine: start 10 mg; target 20-60 mg/day
- Venlafaxine XR: start 37.5 mg; target 75-225 mg/day
- Duloxetine: start 30 mg; target 60-120 mg/day
Medication is part of the answer, not the whole answer.
Cognitive behavioural therapy (CBT) has effect sizes comparable to medication and durable benefit after stopping. The combination of CBT plus an SSRI/SNRI outperforms either alone. Your physician can refer you to a registered psychotherapist or psychologist when you book.
How Long to Stay On Medication
After symptoms remit, evidence supports continuing pharmacotherapy for at least 12 months to reduce the risk of relapse. Some patients benefit from indefinite maintenance with periodic safety reassessment. When stopping, taper gradually (typically one dose-step per month) — abrupt discontinuation, especially of venlafaxine, can cause a flu-like withdrawal syndrome that is unpleasant but not dangerous. If you relapse after stopping, re-starting the previously effective agent is usually successful.
Frequently Asked Questions
Are SSRIs or SNRIs more effective for anxiety?
Both classes are equally effective for generalized anxiety disorder, social anxiety disorder, and panic disorder. A 2021 network meta-analysis of 135 studies and over 30,000 participants found only small, non-significant differences in efficacy between individual SSRIs and SNRIs. By week 8 of treatment, both classes produce comparable clinical outcomes. Choice between them is usually based on side-effect profile, prior response, and Canadian formulary access — not efficacy.
Which SSRI is best for anxiety in Canada?
Sertraline (Zoloft) and escitalopram (Cipralex) are the most commonly recommended SSRIs for anxiety in Canada. Both are widely covered on provincial formularies, well-tolerated, and have strong evidence for GAD, social anxiety disorder, and panic disorder. Paroxetine (Paxil) is also Health Canada–approved for anxiety but has more drug interactions and a harsher discontinuation syndrome.
Which SNRI is best for anxiety in Canada?
Venlafaxine XR (Effexor XR) is the most prescribed SNRI for anxiety in Canada and is Health Canada–approved for GAD, social anxiety disorder, and panic disorder. It is widely available as a generic and covered without restriction on most provincial formularies. Duloxetine (Cymbalta) is approved only for GAD in Canada and may require special authorization for anxiety on some provincial plans.
What are the main differences in side effects between SSRIs and SNRIs?
Both classes share serotonergic side effects: nausea, headache, insomnia, and sexual dysfunction. SNRIs add noradrenergic effects: dose-dependent increases in blood pressure and heart rate, sweating, and a more pronounced discontinuation syndrome (especially venlafaxine). SSRIs are generally safer in patients with cardiovascular disease. Sertraline and fluoxetine have the lowest adverse event rates among SSRIs in head-to-head comparisons.
How long does it take SSRIs and SNRIs to work for anxiety?
Both classes typically begin to reduce anxiety symptoms within 2-4 weeks, with full effect at 4-8 weeks. SSRIs show a linear improvement curve over the acute treatment phase, while SNRIs demonstrate a logarithmic curve with greatest improvement early in treatment. Anxiety patients often need a slower titration than depression patients — start at half the depression dose and increase over 1-2 weeks.
Are SSRIs or SNRIs covered by OHIP, BC PharmaCare, or Alberta Blue Cross?
Generic SSRIs (fluoxetine, paroxetine, citalopram, sertraline) and generic venlafaxine are covered as general benefits across Ontario, BC, and Alberta provincial formularies. Escitalopram (Cipralex) and duloxetine (Cymbalta) often require Limited Use (LU) or Special Authorization (SA) — typically requiring documentation that you tried two other covered antidepressants first. Coverage rules vary; ask your pharmacist to check before filling.
Can I switch from an SSRI to an SNRI if it is not working?
Yes. If a first-line SSRI fails after a 4-8 week therapeutic trial at adequate dose, switching is well-supported. The most common pattern is SSRI to SNRI (about 41% of switches in real-world data). Cross-tapering — gradually decreasing the old medication while introducing the new one — is the preferred method to minimize withdrawal and avoid drug interactions. This should be done with physician guidance.
Are SSRIs or SNRIs safer in pregnancy?
SSRIs are generally preferred over SNRIs in pregnancy due to a more established safety profile. Among SSRIs, sertraline and escitalopram are favored, while paroxetine should be avoided due to a small increased risk of cardiac malformations. SNRIs (venlafaxine, duloxetine) are not contraindicated but have less long-term safety data. Both classes are associated with small increases in preterm birth and neonatal adaptation syndrome — risks that should be weighed against the harms of untreated anxiety in pregnancy.
Should older adults take SSRIs or SNRIs?
SSRIs are generally preferred for adults over 65. A 2025 systematic review found SSRIs produced greater anxiety symptom reduction in older adults than SNRIs (standardized mean difference -1.84 vs -0.46), though response rates were similar. Citalopram should be capped at 20 mg/day in adults over 60 due to QT-prolongation risk. Both classes carry hyponatremia risk in seniors — sodium levels should be monitored.
Can I get an SSRI or SNRI prescription from an online doctor in Canada?
Yes. MediNote physicians are licensed by provincial colleges (CPSO, CPSBC, CPSA, CMQ) and can prescribe SSRIs and SNRIs for anxiety. After a confidential phone consultation, the prescription is sent directly to your pharmacy of choice. Flat $55 CAD fee covers the full consultation, prescription, and a treatment summary.
Sources: Gosmann et al., PLOS Medicine 2021; Mendez et al., CNS Spectrums 2024; Slee et al., The Lancet 2019; Szuhany & Simon, JAMA 2022; Stein & Sareen, NEJM 2015; DeGeorge et al., American Family Physician 2022; Health Canada Drug Product Database; provincial formulary listings (April 2026). This article is for educational purposes and does not constitute medical advice. Reviewed by licensed Canadian physicians.
Want to Talk to a Doctor About Medication for Anxiety?
A licensed Canadian physician can review your symptoms and recommend whether an SSRI, SNRI, or non-medication approach is right for you. Same-day phone consultations, $55 CAD, no referral needed.
Book an Anxiety Consultation